Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).

Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.

The following is a summary of “Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: a monocentric study of 184 patients,” published ...